Company Filing History:
Years Active: 2015-2025
Title: Prapasri Sinswat: Innovator in Pulmonary Drug Delivery
Introduction
Prapasri Sinswat, an esteemed inventor based in Austin, TX, has made significant contributions to the field of pharmaceutical innovations. With a portfolio of 4 patents, Sinswat specializes in the development of advanced compositions for pulmonary drug delivery, particularly focusing on the immunosuppressive drug tacrolimus.
Latest Patents
Her latest inventions demonstrate a groundbreaking approach in creating methods and compositions that enable the rapid dissolution of nanostructured aggregates for pulmonary administration. Specifically, Sinswat's patents detail compositions that utilize a stabilizer matrix, potentially including both polymeric and non-polymeric surfactants. The aggregate achieved by these methods boasts a surface area exceeding 5 m/g, as determined by BET analysis, and maintains supersaturation for a minimum of 0.5 hours when mixed with simulated lung fluid at levels significantly above the aqueous crystalline solubility of tacrolimus.
Career Highlights
Sinswat is currently affiliated with the Massachusetts Institute of Technology, where her research and development efforts focus on innovative drug delivery systems. Her patents embody a critical advancement in achieving enhanced delivery of immunosuppressive drug compositions, showcasing her expertise in pharmaceutical sciences and material engineering.
Collaborations
Throughout her career, Sinswat has worked alongside notable colleagues, including Robert O. Williams, III, and Keith P. Johnston. These collaborations have likely played a pivotal role in her innovative endeavors and have contributed to the successful outcomes of her research projects.
Conclusion
As a leading inventor in her field, Prapasri Sinswat's work exemplifies the intersection of creativity and scientific rigor. Her inventions not only advance the pharmaceutical industry but also enhance patient care through improved drug delivery mechanisms.